Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
Huawei Investment & Holding Co. reported 1H revenue of 467.8 bln yuan and net profit of 23.427 bln yuan.
2026-08-31
Huawei Investment & Holding Co. reported 1H revenue of 467.8 bln yuan and net profit of 23.427 bln yuan.
Back
Other News
2026-08-31
The Bank of Korea warned the semiconductor boom could rekindle inflation if corporate and household income gains translate into consumption. It said rising semiconductor export prices have boosted purchasing power and that, if consumption accelerates
The Bank of Korea warned the semiconductor boom could rekindle inflation if corporate and household income gains translate into consumption. It said rising semiconductor export prices have boosted purchasing power and that, if consumption accelerates, demand may exceed current supply capacity — a demand-side price pressure the central bank cited as one reason for its recent string of atypical consecutive rate hikes.
2026-08-31
The A-share innovative drug sector continued to weaken, with Yuhang Pharmaceutical, Hansen Pharmaceutical, and Jiankai Technology hitting the daily limit down. Toujing Life and Wanbang Pharmaceutical fell by more than 10%, and Zhongguancun, Xidian Ph
The A-share innovative drug sector continued to weaken, with Yuhang Pharmaceutical, Hansen Pharmaceutical, and Jiankai Technology hitting the daily limit down. Toujing Life and Wanbang Pharmaceutical fell by more than 10%, and Zhongguancun, Xidian Pharmaceutical, Qianjin Pharmaceutical, Pris, and Longshen Rongfa and other stocks followed suit.
Chat with us
, powered by
LiveChat